NAFTOPIDIL: 67 Adverse Event Reports & Safety Profile
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
67
Total FAERS Reports
7 (10.4%)
Deaths Reported
39
Hospitalizations
67
As Primary/Secondary Suspect
8
Life-Threatening
2
Disabilities
First Report: 20140326 · Latest Report: 20240126
What Are the Most Common NAFTOPIDIL Side Effects?
#1 Most Reported
Urinary retention
7 reports (10.4%)
#2 Most Reported
Gastroenteritis bacterial
6 reports (9.0%)
#3 Most Reported
Loss of consciousness
5 reports (7.5%)
All NAFTOPIDIL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Urinary retention | 7 | 10.5% | 0 | 6 |
| Gastroenteritis bacterial | 6 | 9.0% | 0 | 6 |
| Loss of consciousness | 5 | 7.5% | 0 | 2 |
Who Reports NAFTOPIDIL Side Effects? Age & Gender Data
Gender: 0.0% female, 100.0% male. Average age: 79.0 years. Most reports from: JP. View detailed demographics →
Is NAFTOPIDIL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 4 | 2 | 3 |
| 2015 | 6 | 0 | 5 |
| 2016 | 8 | 0 | 5 |
| 2017 | 10 | 1 | 7 |
| 2018 | 11 | 2 | 6 |
| 2019 | 4 | 1 | 2 |
| 2020 | 4 | 0 | 3 |
| 2021 | 4 | 0 | 2 |
| 2022 | 6 | 0 | 3 |
| 2023 | 1 | 0 | 0 |
| 2024 | 1 | 0 | 0 |
What Is NAFTOPIDIL Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 29 |
| Benign prostatic hyperplasia | 22 |
Official FDA Label for NAFTOPIDIL
Official prescribing information from the FDA-approved drug label.